WO2024018071A1 - Intrapartum measurement near-infrared spectroscopy device - Google Patents

Intrapartum measurement near-infrared spectroscopy device Download PDF

Info

Publication number
WO2024018071A1
WO2024018071A1 PCT/EP2023/070327 EP2023070327W WO2024018071A1 WO 2024018071 A1 WO2024018071 A1 WO 2024018071A1 EP 2023070327 W EP2023070327 W EP 2023070327W WO 2024018071 A1 WO2024018071 A1 WO 2024018071A1
Authority
WO
WIPO (PCT)
Prior art keywords
intrapartum
infrared spectroscopy
spectroscopy device
fetus
measurement
Prior art date
Application number
PCT/EP2023/070327
Other languages
French (fr)
Inventor
Fabrice Wallois
Thomas Fontaine
Moisés Alberto DOMINGUEZ SANCHEZ
Jeremy LARROUQUERE
Zixi Li
Anne Planat-Chretien
Zadeh MAHDI MAHMOUD
Michel Berger
Original Assignee
Institut National De La Sante Et De La Recherche Medicale
Universite De Picardie Jules Verne
Centre Hospitalier Régional Universitaire D'amiens
Commissariat à l'énergie atomique et aux énergies alternatives
Seenel Imaging
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National De La Sante Et De La Recherche Medicale, Universite De Picardie Jules Verne, Centre Hospitalier Régional Universitaire D'amiens, Commissariat à l'énergie atomique et aux énergies alternatives, Seenel Imaging filed Critical Institut National De La Sante Et De La Recherche Medicale
Publication of WO2024018071A1 publication Critical patent/WO2024018071A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • A61B5/14551—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases
    • A61B5/14553—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases specially adapted for cerebral tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • A61B5/14551—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases
    • A61B5/14552—Details of sensors specially adapted therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • A61B5/1464—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters specially adapted for foetal tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/43—Detecting, measuring or recording for evaluating the reproductive systems
    • A61B5/4306—Detecting, measuring or recording for evaluating the reproductive systems for evaluating the female reproductive systems, e.g. gynaecological evaluations
    • A61B5/4343—Pregnancy and labour monitoring, e.g. for labour onset detection
    • A61B5/4362—Assessing foetal parameters

Definitions

  • the present invention concerns an intrapartum measurement near-infrared spectroscopy device.
  • the present invention also relates to an intrapartum measurement device comprising such spectroscopy device as well as a delivery monitoring system also comprising the spectroscopy device.
  • the infant makes the critical transition from its dependence on maternal and placental support, oxidative, nutritional, and endocrinological, and establishes independent life.
  • the difficulty of this transition is indicated by mortality risks that are higher than any occurring until old age and by risks for damage to organ systems, most notably the brain that can be lifelong.
  • the fetus has risk of severe hypoxia and metabolic acidosis.
  • Oxygen is the most vital substrate necessary for mitochondrial respiration and is not stored in the body. Interruption of oxygen supply to cells can result in irreversible brain damage. Cerebral palsy due to intrapartum anoxia is one of the most deleterious consequences of labor.
  • the monitoring fetal heart rate (FHR) is currently considered as the gold standard for evaluating fetal status.
  • FHR monitoring has shown to have low false-negative and high falsepositive rates.
  • the specification describes an intrapartum near-infrared spectroscopy device adapted to carry out a near-infrared spectroscopy on the fetus’s brain, the intrapartum near-infrared spectroscopy device comprising a near-infrared spectroscopy sensor and a processing circuitry.
  • the near-infrared spectroscopy sensor is a fibered component comprising a light source and at least two light detectors, the light detectors being arranged to collect the light emitted by the fetus’s brain at two distinct locations.
  • the light emitted by the fetus’s brain comprises a contribution from the surface of the skin of the fetus and a contribution from the brain.
  • the processing circuitry is adapted to receive the signals coming from the light detectors and to process the signals of the light detectors to filter the contribution of the surface by comparing the signals coming from the light detectors and applying a diffusion model.
  • This part is useful with regards to the considered application of intrapartum measurement, and more precisely controlling the fetus’s health.
  • the intrapartum near-infrared spectroscopy device might incorporate one or several of the following features, taken in any technically admissible combination:
  • the light source comprises several excitation sources combined by couplers.
  • each central wavelength is defined, each central wavelength being comprised between 600 nanometers and 1100 nanometers.
  • each central wavelength is defined, each central wavelength being comprised between 620 nanometers and 970 nanometers.
  • each central wavelength is defined, each central wavelength being comprised between 600 nanometers and 1 100 nanometers.
  • each central wavelength is comprised between 700 nanometers and 900 nanometers.
  • each light detector is provided with a fiber.
  • at least one fiber is a PMMA multimode fiber.
  • at least one fiber is a series of a PMMA multimode fiber and a SiC>2 multimode fiber.
  • - at least one fiber is provided with a prism.
  • the near-infrared spectroscopy sensor comprises more than three light detectors, notably four light detectors.
  • the distance between one location and the nearest location is comprised between 2 millimeters and 15 millimeters.
  • the specification also describes an intrapartum measurement device comprising an intrapartum near-infrared spectroscopy device as previously described.
  • the intrapartum measurement device may further comprise a electroencephalography device.
  • the specification also concerns a delivery monitoring system comprising an intrapartum measurement device as previously described.
  • the specification also proposes an intrapartum measurement probe adapted to measure signals of the fetus’s brain, the intrapartum measurement probe comprising a housing and a mechanical support.
  • the housing comprises an electroencephalography sensor adapted to measure electrical signals of the fetus’s brain and a near-infrared spectroscopy sensor adapted to measure fetal tissue oximetry.
  • the mechanical support is adapted to fix the housing to the scalp or the head of the fetus.
  • the intrapartum measurement probe might incorporate one or several of the following features, taken in any technically admissible combination:
  • the electroencephalography sensor comprises two Ag/AgCI electrodes.
  • each electrode is used as an electromyography sensor and/or an impedance sensor.
  • the housing is made of two parts, each part having the form of a cup.
  • the mechanical support comprises a connecting structure linking the two parts and, for each part, respectively a control rod and a cable.
  • the mechanical support comprises a holding element adapted to hold the housing, the holding element having preferably a cup form in transverse section.
  • the mechanical support further comprises a protecting element adapted to protect the housing.
  • the intrapartum measurement probe further comprises a pressure sensor.
  • the specification also relates to an intrapartum measurement device comprising an intrapartum measurement probe as previously described, a first processing unit adapted to process the signals coming from the electroencephalography sensor, and a second processing unit adapted to process the signals coming from the near-infrared spectroscopy sensor.
  • the probe proposes a combination of two sensors, which have never been associated on the same probe in the specific context of intrapartum measurement.
  • the transposition of a technique from an adult to a foetus is generally not desirable, since it is very complicated to solve these cross-talk and heating issues.
  • the position of the housing is specific.
  • the sensors are provided on the uterine wall so as to ensure a reproducible measurement.
  • the probe is here maintained on the scalp of the fetus, thereby enabling correct measurements.
  • Such probe enables to accurately and rapidly recognize oxygen delivery and tissue hypoxia in the critically labor situation.
  • the intrapartum measurement device might incorporate one or several of the following features, taken in any technically admissible combination:
  • the first processing unit and the second processing unit operate in an asynchronous manner.
  • the first processing unit comprises a filtering unit adapted to filter the movement artifacts generated in the signals coming from the electroencephalography sensor.
  • the specification also describes a delivery monitoring system comprising an intrapartum measurement device as previously described.
  • the delivery monitoring system might incorporate one or several of the following features, taken in any technically admissible combination: the delivery monitoring system further comprises measurement devices adapted to measure physical values relative to the mother. the delivery monitoring system further comprises measurement devices adapted to measure physical values relative to the fetus, the measurement devices being positioned outside the uterus.
  • figure 1 is a schematic view of a delivery monitoring system comprising a intrapartum measurement device, which comprises an intrapartum measurement probe and a processing circuit
  • - figure 2 is a schematic view of the intrapartum measurement probe of figure 1 in position
  • FIG. 3 is a perspective view of an electrode of the electroencephalography sensor of the intrapartum measurement probe
  • figure 4 is a schematic view of a near-infrared spectroscopy device of the intrapartum measurement device of figure 1 ,
  • FIG. 5 is a perspective view of the intrapartum measurement probe including a mechanical support
  • FIG. 6 is a view of a first part of the mechanical support
  • FIG. 7 is a view in transverse section of the first part according to the axis VI-VI,
  • FIG. 8 is a view of a second part of the mechanical support equipped with a housing
  • figure 9 is an exploded view of the elements represented on figure 8,
  • FIG. 10 is a view of another example of mechanical support.
  • figure 11 is another view of the mechanical support of figure 10.
  • a delivery monitoring system 10 is illustrated schematically on figure 1 .
  • the delivery monitoring system 10 is adapted to monitor several physical values of the mother and of the fetus in a delivery room.
  • the delivery monitoring system 10 may be construed as a set of measurement devices.
  • the focus is on a specific part of the delivery monitoring system 10, which is the intrapartum measurement device 22.
  • intrapartum measurement device 22 So as to better understand the environment of such intrapartum measurement device 22, it seems important to describe an environment in which the intrapartum measurement device 22 may be used. This will notably enable to distinguish the intrapartum measurement device 22 from other measurement devices that can be found in a delivery room.
  • Each measurement device comprises a sensor, a processing circuit and an output unit.
  • the measurement devices measure physical values either of the mother either of the fetus.
  • the measurement devices providing with physical values relative to the mother are named mother measurement devices 12.
  • the mother measurement devices 12 comprise a heart rate detector, an abdominal electrode or any measuring device that can be relevant in the context.
  • mother measurement devices 12 Although in general all these mother measurement devices 12 are separate elements, they are represented as a unique measurement device in figure 1 .
  • the delivery monitoring system 10 comprises a mother sensor block 14, a mother processing circuit block 16 and a mother output unit block 18.
  • the physical values are either measured from outside or intrapartum.
  • outside fetus measurement devices 20 the measurement devices providing with physical values relative to the fetus from outside are named outside fetus measurement devices 20 and the measurement device providing with physical values relative to the fetus intrapartum is named intrapartum measurement device 22.
  • the outside fetus measurement devices 20 comprise a heart rate detector or any measuring device that can be relevant in the context.
  • the delivery monitoring system 10 comprises an outside fetus sensor block 24, an outside fetus processing circuit block 26 and an outside fetus output unit block 28.
  • the intrapartum measurement device 22 is illustrated in position, this is inside the uterus, on figure 2.
  • the intrapartum measurement device 22 is a device adapted to measure signals of the fetus’s brain.
  • the intrapartum measurement device 22 comprises an intrapartum measurement probe 29 made of a housing 30 and a mechanical support 32, which can be seen on figures 5 to 9.
  • the housing 30 comprises an electroencephalography sensor 34 and a near infra-red spectroscopy sensor 36.
  • electroencephalography sensor 34 is named EEG sensor 34, EEG being the abbreviation of electroencephalography.
  • the near-infrared spectroscopy sensor 36 is named NIRS 36 sensor hereinafter.
  • NIRS being the abbreviation of near-infrared spectroscopy.
  • the intrapartum measurement device 22 is a bimodal measurement device for the fetus’s brain since it comprises two distinct measurement modalities, namely a first modality corresponding to the EEG sensor and a second modality corresponding to the NIRS sensor.
  • the EEG sensor 34 is part of a EEG device 38, which also comprises an EEG processing circuit 40 and a EEG output unit 42.
  • the NIRS sensor 36 is part of a NIRS device 44, which also comprises a NIRS processing circuit 46 and a NIRS output unit 48.
  • each processing circuit is controlled by a controller 50, which is part of a computer 52.
  • This computer 52 is also provided with a display device 54, which is a screen. Such display device 54 is shared by the different measurement devices 12, 20 and 22.
  • the mother output unit block 18, the outside fetus output unit block 28, the EEG output unit 42 and the NIRS output unit 48 are realized as a unique unit, which is the display device 54.
  • the display device 54 may display one or several of the following physical values: the value of the fetal EEG, the values of cerebral hemodynamics, the value or the fetal heart rate, the value of the maternal heart rate and the value of the contractions.
  • the EEG processing circuit 40 and the NIRS processing circuit 46 are realized on the same PCB (printed cardboard) so that they share similar components.
  • the set of the EEG processing circuit 40 and the NIRS processing circuit 46 forms a probe processing circuit 56.
  • the EEG processing circuit 40 and the NIRS processing circuit 46 are separate and are realized on different PCBs.
  • the EEG sensor 34 is adapted to measure electrical signals of the fetus’s brain.
  • the electrical signals of the fetus’s brain correspond to the neuronal activity of the fetus’s brain.
  • the EEG sensor 34 is a sensor adapted to acquire the neuronal activity of the fetus’s brain.
  • the EEG sensor 34 comprises two electrodes 58, each of these electrodes being an Ag/AgCI electrode.
  • One electrode 58 is represented on figure 3.
  • Each electrode 58 has a cylindrical shape 62.
  • the basis of the cylindrical shape 62 is a circle whose diameter D is comprised between 1 mm and 8 mm.
  • the height H of the cylindrical shape 62 is preferably inferior to the diameter of the circle.
  • Each electrode 58 is connected to an embedded wire 64, notably a silver wire. This renders connected to any cable or other conductive media by soldering or crimping them to the embedded wire 64.
  • These sintered Ag/AgCI electrodes 58 are very adapted to this specific case of intrapartum measurement. They notably enable to extract more information from a small fetus brain, allowing more degrees of freedom, since they benefit from the low noise level it generates during biological signals recording.
  • the electrodes 58 can be used to record uterus contraction by being used as an electromyography (EMG) sensor.
  • EEG electromyography
  • the EEG is on the side of the head of the fetus while the EMG is on the side of the uterine wall.
  • the record uterus contraction can be carried out by a pressure sensor.
  • the electrodes 58 can also be used to carry out an impedance measurement to measure the probe attachment.
  • the impedance measured here is the impedance of the skin with which the probe is attached.
  • the NIRS sensor 36 is adapted to measure fetal tissue oximetry.
  • the NIRS sensor 36 is adapted to measure the fetal cerebral oximetry.
  • the NIRS sensor 36 is a fibered component.
  • a fiber component enables to meet security constraints on the one hand, and to avoid cross-talk between modalities on the other hand.
  • the NIRS sensor 36 comprises a light source 64 and at least two light detectors 66, four in the case of the example of figure 4.With the Applicant’s tries, four appears to be a good trade-off between precision and low volume of the NIRS sensor.
  • the light source 64 is formed by the excitation coming from several excitation sources 68.
  • Each excitation source 68 is a fibered LED.
  • a central wavelength can be defined.
  • the NIRS sensor 36 is adapted to send a minimum of 2 central wavelengths in an optical windows in NIRS corresponding to the biological tissue, namely between 600 nanometers (nm) and 1100 nm.
  • each light detector a central wavelength is defined, each central wavelength being comprised between 600 nanometers and 1100 nanometers.
  • the number of excitation sources 68 is equal to three and each of the central wavelengths are comprised between 620 nm and 970 nm, preferably between 720 nm and 900 nm.
  • the excitation sources 68 are combined by optical couplers 70. Other means can nevertheless be considered.
  • the light detectors 66 are arranged to collect the light emitted by the fetus’s brain in response to the light emitted by the light source 64 at four different locations.
  • each light detector 64 is provided with a respective fiber 72.
  • the fiber 72 is a PMMA multimode fiber.
  • the fiber 72 is a set of a PMMA multimode fiber followed by a SiC>2 multimode fiber.
  • a set of fiber in SiC>2 with a prism is used.
  • the collection of the light emitted by the fetus’s brain at different locations enables to separate two contributions, one coming from systemic contribution (from the surface of the skin of the fetus) and the other one coming from the brain (deep contribution).
  • the NIRS device 44 is a functional NIRS device since it is adapted to provide with in-depth quantitative estimation of oxygenation variations by separating systemic variations (surface area) from cerebral variations.
  • the NIRS device can be used for separating the layers contribution, in order to access the oxygen information at the ‘brain level’.
  • the NIRS processing circuitry 46 is adapted to receive the signals measured by each light detector 66.
  • the NIRS processing circuitry 46 is further adapted to process the signals of the light detectors to filter the contribution of the surface by comparing the signals coming from the light detectors 66 and applying a diffusion model.
  • the diffusion model could be derived from Beer-Lambert law or by using a spatially resolved spectroscopy technique, often named SRS technique.
  • SRS technique is notably used in NIRS to obtain tissue oxygenation index (TOI).
  • TOI tissue oxygenation index
  • the minimal contamination from superficial layers is obtained by measuring the gradient of light-intensity attenuation at multiple wavelengths.
  • a set of closely placed detectors is used at nearly the same source-detector distance, large enough to probe the cerebral tissue
  • the filtering part corresponds to exploiting the property according to which it is generally considered that the tissue depth imaged is equal to half the distance between the emitter and the detector. This means that for short distances between the emitter and the detector (short channel) only the surface contribution is obtained and for long distances between an emitter and the corresponding detector (long channel), surface and cerebral tissue are imaged. By smartly filtering the long channel images by one or several short channel images, the systemic contribution is eliminated.
  • the four locations are aligned.
  • the locations are arranged along other forms, such as circle or a square
  • the distance between one location and the nearest location be comprised between 2 mm and 15 mm.
  • the mechanical support 32 comprises two parts: a holding element 74 and a protecting element 76.
  • the holding element 74 can be viewed in more details on figures 6 and 7.
  • the holding element 74 is adapted both to hold the housing 30 and ensure that the intrapartum measurement probe 29 be held in place by pressure, wedged between the head of the fetus and the uterine wall.
  • the holding element 74 is made in a gecko adhesive material.
  • the holding element 74 comprises a central portion 78 and a peripheral portion 80 surrounding the central portion.
  • the holding element 74 has a general form of a rectangle while seen from a side, the transversal section (along the axis VI-VI on figure 6) has a form of a cup 82 with a bottom 84 and two sides 86 extending from the bottom towards the exterior.
  • the bottom 84 of the cup 82 corresponds to the central portion 78 while the sides 86 of the cup 82 correspond to the peripheral portion 80.
  • the bottom 84 and each side 86 form an angle comprised between 35° and 45°.
  • angles formed by the bottom 84 and each side 86 have the same values to simplify the manufacturing (by molding notably) of the holding element 74.
  • the central portion 78 is provided with fixing elements 88.
  • the fixing elements 88 protrude from the central portion 78 and are intended to collaborate with complementary elements present on a face 90 of the housing 30.
  • the other face 92 has a rectangular shape with a length comprised between 20 mm and 40 mm and a width comprised between 4 mm and 10 mm.
  • the other face 92 comprises seven openings : two for the electrodes (electrode opening 94 hereinafter), one for the insertion of the fiber of the light source (light source opening 96 hereinafter) and four for the insertion of the fours fibers of the light detectors (light detector opening 98 hereinafter).
  • the distance between the two electrode openings 94 is comprised between 15 mm and 30 mm.
  • the distance between the light source opening 96 and the nearest light detector opening 98 is comprised between 2 mm and 20 mm.
  • One electrode opening 94 is located in front of the light source opening 96 while the other electrode opening 94 is located between two light detector openings 98, more precisely between the central light detector openings 98.
  • the fibers 72 are fixed by one lateral side 100 of the housing 30, which enables to obtain a quite low voluminous housing 30.
  • the lateral side is provided with holding openings 102 through with the fibers 72 are inserted.
  • the protecting element 76 is adapted to protect the openings 94, 96 and 98, and more precisely the sensors 34 and 36.
  • the housing 30 comprises here two parts 110 and 112.
  • the different elements of the intrapartum measurement probe are shared between the two parts 1 10 and 112.
  • Each part 1 10 and 112 has the general form of a cup.
  • each part 110 and 112 holds on the head of the fetus by suction, so that the parts 110 and 1 12 correspond a suction cup.
  • the mechanical support 32 comprises a connecting structure 114 linking the two parts 1 10 and 1 12 and, for each part 110 and 112, respectively a control rod 116 and a cable 1 18.
  • each control rod 1 16 is linked to its respective part 110 or 112 by a receptacle 120, the receptacle being fixed to the bottom of the part 110 or 112.
  • the control rods 1 16 enable to control the angle between the two parts 110 and 1 12 by pushing one and/or pulling the other one.
  • Each cable 118 embeds one beam of optical fibers.
  • the EEG processing circuit 40 and the NIRS processing circuit 46 have different sampling rates so that they work in an asynchronous manner.
  • the probe processing circuit 56 is provided with a synchronization unit adapted to synchronize the data coming from the EEG processing circuit and the NIRS processing circuit by using their local timestamp.
  • each of the EEG processing circuit 40 and the NIRS processing circuit 46 are able to timestamp an element with a timestamp derived from their own sampling rates.
  • the synchronization unit will thus calculate the real time and synchronize the data with the same “absolute” timestamp.
  • the intrapartum measurement device 22 enables to address the challenge of designing and developing a device and probe that provide reliable access for the monitoring of fetal cerebral oxygenation simultaneously to neuronal activity and heart rate while the cervix must be sufficiently dilated and the membranes ruptured.
  • the scalp is covered by hair, and mucous, blood etc., all of which can interfere with light transmission and photodetection.
  • a good contact between the probe and the skin should also be obtained while pressure sores from the probes should be minimized.
  • the present intrapartum measurement device 22 fulfills many technical constraints, among which medical constraints of maneuverability, accessibility, compatibility, technical constraints related to electrodes and EEG signal analysis, technical constraints related NIRS carrying out and NIRS signal analysis and modality mergers constraints.
  • Such intrapartum measurement device 22 is provided with synchronization and the real-time functionalities, which renders such device adapted to be used as an autonomous monitoring device.
  • Combining an EEG sensor 34 and a NIRS sensor 16 in the same intrapartum measurement device 22 provides with a simultaneous measurement bimodality ability. Such property enables to address the function/dysfunction of both hemodynamic and neuronal activities independently but also conjointly so as to minimize misleading interpretation arising from one or the other modalities.
  • the intrapartum measurement device 22 also provides with a better understanding of the mechanisms involved in this situation of normal or pathological delivery.
  • intrapartum measurement device 22 enables to address specifically neurovascular origin and consequences of an acute cerebral distress during delivery. Such knowledge enables to prevent neurological sequels of postpartum, which appear later in development and can be declined in the form of various brain diseases ranging from death, cerebral palsy and cognitive disorders.
  • the intrapartum measurement device 22 also provides with information on cerebral function / dysfunction in all situations where one or the other of the modalities would be inoperative, thus making it possible to go beyond the limits of each of the techniques that have hitherto been proposed.
  • the intrapartum measurement device 22 enables to accurately and rapidly recognize oxygen delivery and tissue hypoxia in the critical labor situation.
  • the intrapartum measurement device 22 also strengthens the bundle of arguments considering the opportunity of a C-section.
  • the intrapartum measurement device 22 further comprises a set of biosensors.
  • the intrapartum measurement device 22 also comprise a pressure sensor.
  • the intrapartum measurement device 22 is provided with a specific detecting module.
  • the detecting module comprises a filtering unit.
  • the filtering unit is adapted reduce the EEG signal contamination induced by movement artifacts, notably labor.
  • the movement artifacts may be detected by using the pressure sensor mentioned in the first example of this paragraph.
  • the detecting module may also comprises a preamplifier with high common-mode rejection ratio and high signal-to-noise ratio.

Abstract

The present invention relates to the monitoring of the labor period. The gold standard is currently the monitoring of fetal heart rate (FHR). However, the FHR monitoring is not satisfying since it leads to low false-negative and high false-positive rates. That's why the inventors worked on a more accurate device. Thus, the present invention proposes a device adapted to achieve a smart NIRS spectroscopy which enables to accurately and rapidly recognize oxygen delivery and tissue hypoxia in the critically labor situation.

Description

INTRAPARTUM MEASUREMENT NEAR-INFRARED SPECTROSCOPY DEVICE
TECHNICAL FIELD OF THE INVENTION
The present invention concerns an intrapartum measurement near-infrared spectroscopy device. The present invention also relates to an intrapartum measurement device comprising such spectroscopy device as well as a delivery monitoring system also comprising the spectroscopy device.
BACKGROUND OF THE INVENTION
During the labor period, the infant makes the critical transition from its dependence on maternal and placental support, oxidative, nutritional, and endocrinological, and establishes independent life. The difficulty of this transition is indicated by mortality risks that are higher than any occurring until old age and by risks for damage to organ systems, most notably the brain that can be lifelong. During the labor period, the fetus has risk of severe hypoxia and metabolic acidosis. Oxygen is the most vital substrate necessary for mitochondrial respiration and is not stored in the body. Interruption of oxygen supply to cells can result in irreversible brain damage. Cerebral palsy due to intrapartum anoxia is one of the most deleterious consequences of labor.
The monitoring fetal heart rate (FHR) is currently considered as the gold standard for evaluating fetal status.
However, FHR monitoring has shown to have low false-negative and high falsepositive rates.
SUMMARY OF THE INVENTION
There is a need for developing systems enabling to accurately and rapidly recognize oxygen delivery and tissue hypoxia in the critically labor situation.
To this end, the specification describes an intrapartum near-infrared spectroscopy device adapted to carry out a near-infrared spectroscopy on the fetus’s brain, the intrapartum near-infrared spectroscopy device comprising a near-infrared spectroscopy sensor and a processing circuitry. The near-infrared spectroscopy sensor is a fibered component comprising a light source and at least two light detectors, the light detectors being arranged to collect the light emitted by the fetus’s brain at two distinct locations. The light emitted by the fetus’s brain comprises a contribution from the surface of the skin of the fetus and a contribution from the brain. The processing circuitry is adapted to receive the signals coming from the light detectors and to process the signals of the light detectors to filter the contribution of the surface by comparing the signals coming from the light detectors and applying a diffusion model.
Such removing of the systemic component is different from the filters applied in the prior art documents, such as documents WO 2021/195299 A1 , US 2004/116789 A1 , US 6 175 753 B1 and US 2016/089067 A1 .
Such filters applied in the prior art documents are only trying to improving the quality of the signal, and notably parasite signal, whereas the proposed filter is adapted to select the useful part of the signal.
This part is useful with regards to the considered application of intrapartum measurement, and more precisely controlling the fetus’s health.
According to further aspects of the intrapartum near-infrared spectroscopy device, which are advantageous but not compulsory, the intrapartum near-infrared spectroscopy device might incorporate one or several of the following features, taken in any technically admissible combination:
- the light source comprises several excitation sources combined by couplers.
- for each light detector, a central wavelength is defined, each central wavelength being comprised between 600 nanometers and 1100 nanometers.
- for each excitation source, a central wavelength is defined, each central wavelength being comprised between 620 nanometers and 970 nanometers.
- for each excitation source, a central wavelength is defined, each central wavelength being comprised between 600 nanometers and 1 100 nanometers.
- each central wavelength is comprised between 700 nanometers and 900 nanometers.
- the number of excitation sources is superior to 3.
- each light detector is provided with a fiber. at least one fiber is a PMMA multimode fiber. at least one fiber is a series of a PMMA multimode fiber and a SiC>2 multimode fiber.
- at least one fiber is provided with a prism.
- the near-infrared spectroscopy sensor comprises more than three light detectors, notably four light detectors.
- the locations are aligned.
- the distance between one location and the nearest location is comprised between 2 millimeters and 15 millimeters. The specification also describes an intrapartum measurement device comprising an intrapartum near-infrared spectroscopy device as previously described.
The intrapartum measurement device may further comprise a electroencephalography device.
The specification also concerns a delivery monitoring system comprising an intrapartum measurement device as previously described.
The specification also proposes an intrapartum measurement probe adapted to measure signals of the fetus’s brain, the intrapartum measurement probe comprising a housing and a mechanical support. The housing comprises an electroencephalography sensor adapted to measure electrical signals of the fetus’s brain and a near-infrared spectroscopy sensor adapted to measure fetal tissue oximetry. The mechanical support is adapted to fix the housing to the scalp or the head of the fetus.
According to further aspects of the intrapartum measurement probe, which are advantageous but not compulsory, the intrapartum measurement probe might incorporate one or several of the following features, taken in any technically admissible combination:
- the electroencephalography sensor comprises two Ag/AgCI electrodes.
- each electrode is used as an electromyography sensor and/or an impedance sensor.
- the housing is made of two parts, each part having the form of a cup.
- the mechanical support comprises a connecting structure linking the two parts and, for each part, respectively a control rod and a cable.
- the mechanical support comprises a holding element adapted to hold the housing, the holding element having preferably a cup form in transverse section.
- the mechanical support further comprises a protecting element adapted to protect the housing.
- the intrapartum measurement probe further comprises a pressure sensor.
The specification also relates to an intrapartum measurement device comprising an intrapartum measurement probe as previously described, a first processing unit adapted to process the signals coming from the electroencephalography sensor, and a second processing unit adapted to process the signals coming from the near-infrared spectroscopy sensor.
Such probe is very original for several reasons.
The probe proposes a combination of two sensors, which have never been associated on the same probe in the specific context of intrapartum measurement.
Other associations of probe are generally used in this context, such as optical sensor and EEG sensor, as notably illustrated by document US 5 109 849 A. The context of intrapartum measurement is very specific in so far as the allocated space is very reduced, notably resulting in cross-talk and heating issues.
In particular, the transposition of a technique from an adult to a foetus is generally not desirable, since it is very complicated to solve these cross-talk and heating issues.
Furthermore, the position of the housing is specific.
Generally, the sensors are provided on the uterine wall so as to ensure a reproducible measurement.
On the contrary, the probe is here maintained on the scalp of the fetus, thereby enabling correct measurements.
Such probe enables to accurately and rapidly recognize oxygen delivery and tissue hypoxia in the critically labor situation.
According to further aspects of the intrapartum measurement device, which are advantageous but not compulsory, the intrapartum measurement device might incorporate one or several of the following features, taken in any technically admissible combination:
- the first processing unit and the second processing unit operate in an asynchronous manner.
- the first processing unit comprises a filtering unit adapted to filter the movement artifacts generated in the signals coming from the electroencephalography sensor.
The specification also describes a delivery monitoring system comprising an intrapartum measurement device as previously described.
According to further aspects of the delivery monitoring system, which are advantageous but not compulsory, the delivery monitoring system might incorporate one or several of the following features, taken in any technically admissible combination: the delivery monitoring system further comprises measurement devices adapted to measure physical values relative to the mother. the delivery monitoring system further comprises measurement devices adapted to measure physical values relative to the fetus, the measurement devices being positioned outside the uterus.
BRIEF DESCRIPTION OF THE DRAWINGS
The invention will be better understood on the basis of the following description which is given in correspondence with the annexed figures and as an illustrative example, without restricting the object of the invention. In the annexed figures: figure 1 is a schematic view of a delivery monitoring system comprising a intrapartum measurement device, which comprises an intrapartum measurement probe and a processing circuit, - figure 2 is a schematic view of the intrapartum measurement probe of figure 1 in position,
- figure 3 is a perspective view of an electrode of the electroencephalography sensor of the intrapartum measurement probe,
- figure 4 is a schematic view of a near-infrared spectroscopy device of the intrapartum measurement device of figure 1 ,
- figure 5 is a perspective view of the intrapartum measurement probe including a mechanical support,
- figure 6 is a view of a first part of the mechanical support,
- figure 7 is a view in transverse section of the first part according to the axis VI-VI,
- figure 8 is a view of a second part of the mechanical support equipped with a housing,
- figure 9 is an exploded view of the elements represented on figure 8,
- figure 10 is a view of another example of mechanical support, and
- figure 11 is another view of the mechanical support of figure 10.
DETAILED DESCRIPTION OF SOME EMBODIMENTS
Description of the components of the delivery monitoring system
A delivery monitoring system 10 is illustrated schematically on figure 1 .
The delivery monitoring system 10 is adapted to monitor several physical values of the mother and of the fetus in a delivery room.
The delivery monitoring system 10 may be construed as a set of measurement devices.
In the present case, the focus is on a specific part of the delivery monitoring system 10, which is the intrapartum measurement device 22.
So as to better understand the environment of such intrapartum measurement device 22, it seems important to describe an environment in which the intrapartum measurement device 22 may be used. This will notably enable to distinguish the intrapartum measurement device 22 from other measurement devices that can be found in a delivery room.
The environment is thus described hereinafter as a specific example, bearing in mind that such example is not limitative.
Each measurement device comprises a sensor, a processing circuit and an output unit. The measurement devices measure physical values either of the mother either of the fetus.
The measurement devices providing with physical values relative to the mother are named mother measurement devices 12.
For instance, the mother measurement devices 12 comprise a heart rate detector, an abdominal electrode or any measuring device that can be relevant in the context.
Although in general all these mother measurement devices 12 are separate elements, they are represented as a unique measurement device in figure 1 .
Therefore, the delivery monitoring system 10 comprises a mother sensor block 14, a mother processing circuit block 16 and a mother output unit block 18.
Concerning the fetus, the physical values are either measured from outside or intrapartum.
For clarity, the measurement devices providing with physical values relative to the fetus from outside are named outside fetus measurement devices 20 and the measurement device providing with physical values relative to the fetus intrapartum is named intrapartum measurement device 22.
For instance, the outside fetus measurement devices 20 comprise a heart rate detector or any measuring device that can be relevant in the context.
Similarly to the mother measurement devices 12, although in general all these outside fetus measurement devices 20 are separate elements, they are represented as a unique measurement device in figure 1 .
Therefore, the delivery monitoring system 10 comprises an outside fetus sensor block 24, an outside fetus processing circuit block 26 and an outside fetus output unit block 28.
The intrapartum measurement device 22 is illustrated in position, this is inside the uterus, on figure 2.
The intrapartum measurement device 22 is a device adapted to measure signals of the fetus’s brain.
The intrapartum measurement device 22 comprises an intrapartum measurement probe 29 made of a housing 30 and a mechanical support 32, which can be seen on figures 5 to 9.
The housing 30 comprises an electroencephalography sensor 34 and a near infra-red spectroscopy sensor 36.
Hereinafter, the electroencephalography sensor 34 is named EEG sensor 34, EEG being the abbreviation of electroencephalography.
Similarly, the near-infrared spectroscopy sensor 36 is named NIRS 36 sensor hereinafter. NIRS being the abbreviation of near-infrared spectroscopy. As an initial comment, it can be noticed that the intrapartum measurement device 22 is a bimodal measurement device for the fetus’s brain since it comprises two distinct measurement modalities, namely a first modality corresponding to the EEG sensor and a second modality corresponding to the NIRS sensor.
The EEG sensor 34 is part of a EEG device 38, which also comprises an EEG processing circuit 40 and a EEG output unit 42.
Similarly, the NIRS sensor 36 is part of a NIRS device 44, which also comprises a NIRS processing circuit 46 and a NIRS output unit 48.
In the present case of figure 1 , each processing circuit is controlled by a controller 50, which is part of a computer 52.
This computer 52 is also provided with a display device 54, which is a screen. Such display device 54 is shared by the different measurement devices 12, 20 and 22.
This means that the mother output unit block 18, the outside fetus output unit block 28, the EEG output unit 42 and the NIRS output unit 48 are realized as a unique unit, which is the display device 54.
As a consequence, according to the embodiments, the display device 54 may display one or several of the following physical values: the value of the fetal EEG, the values of cerebral hemodynamics, the value or the fetal heart rate, the value of the maternal heart rate and the value of the contractions.
Furthermore, the EEG processing circuit 40 and the NIRS processing circuit 46 are realized on the same PCB (printed cardboard) so that they share similar components. The set of the EEG processing circuit 40 and the NIRS processing circuit 46 forms a probe processing circuit 56.
However, according to another embodiment the EEG processing circuit 40 and the NIRS processing circuit 46 are separate and are realized on different PCBs.
Description of an example of EEG sensor 34
The EEG sensor 34 is adapted to measure electrical signals of the fetus’s brain.
The electrical signals of the fetus’s brain correspond to the neuronal activity of the fetus’s brain.
Therefore, the EEG sensor 34 is a sensor adapted to acquire the neuronal activity of the fetus’s brain.
The EEG sensor 34 comprises two electrodes 58, each of these electrodes being an Ag/AgCI electrode.
One electrode 58 is represented on figure 3.
Each electrode 58 has a cylindrical shape 62. The basis of the cylindrical shape 62 is a circle whose diameter D is comprised between 1 mm and 8 mm.
The height H of the cylindrical shape 62 is preferably inferior to the diameter of the circle.
Each electrode 58 is connected to an embedded wire 64, notably a silver wire. This renders connected to any cable or other conductive media by soldering or crimping them to the embedded wire 64.
These sintered Ag/AgCI electrodes 58 are very adapted to this specific case of intrapartum measurement. They notably enable to extract more information from a small fetus brain, allowing more degrees of freedom, since they benefit from the low noise level it generates during biological signals recording.
In addition, the electrodes 58 can be used to record uterus contraction by being used as an electromyography (EMG) sensor. In such configuration, the EEG is on the side of the head of the fetus while the EMG is on the side of the uterine wall.
Alternatively, the record uterus contraction can be carried out by a pressure sensor.
The electrodes 58 can also be used to carry out an impedance measurement to measure the probe attachment. The impedance measured here is the impedance of the skin with which the probe is attached.
Description of an example of NIRS device 44
The NIRS sensor 36 is adapted to measure fetal tissue oximetry.
Given the position of the intrapartum measurement device 22, this means that the NIRS sensor 36 is adapted to measure the fetal cerebral oximetry.
In the present case, the NIRS sensor 36 is a fibered component.
A fiber component enables to meet security constraints on the one hand, and to avoid cross-talk between modalities on the other hand.
It can be noted here that using a fibered component is a way of fulfilling such constraints but other means could be considered such as embedded led and detector into the probe or electronic connection with the main board or communication through wireless connection.
More precisely, the NIRS sensor 36 comprises a light source 64 and at least two light detectors 66, four in the case of the example of figure 4.With the Applicant’s tries, four appears to be a good trade-off between precision and low volume of the NIRS sensor.
The light source 64 is formed by the excitation coming from several excitation sources 68.
Each excitation source 68 is a fibered LED. For each of these excitation sources 68, a central wavelength can be defined.
The NIRS sensor 36 is adapted to send a minimum of 2 central wavelengths in an optical windows in NIRS corresponding to the biological tissue, namely between 600 nanometers (nm) and 1100 nm.
This means that for, each light detector, a central wavelength is defined, each central wavelength being comprised between 600 nanometers and 1100 nanometers.
In the present case, the number of excitation sources 68 is equal to three and each of the central wavelengths are comprised between 620 nm and 970 nm, preferably between 720 nm and 900 nm.
The excitation sources 68 are combined by optical couplers 70. Other means can nevertheless be considered.
The light detectors 66 are arranged to collect the light emitted by the fetus’s brain in response to the light emitted by the light source 64 at four different locations.
For this, each light detector 64 is provided with a respective fiber 72.
According to a first example, the fiber 72 is a PMMA multimode fiber.
According to another example, so as to limit the loss, the fiber 72 is a set of a PMMA multimode fiber followed by a SiC>2 multimode fiber.
According to still another example, a set of fiber in SiC>2 with a prism is used.
The collection of the light emitted by the fetus’s brain at different locations enables to separate two contributions, one coming from systemic contribution (from the surface of the skin of the fetus) and the other one coming from the brain (deep contribution).
In that sense, the NIRS device 44 is a functional NIRS device since it is adapted to provide with in-depth quantitative estimation of oxygenation variations by separating systemic variations (surface area) from cerebral variations. The NIRS device can be used for separating the layers contribution, in order to access the oxygen information at the ‘brain level’.
For this, the NIRS processing circuitry 46 is adapted to receive the signals measured by each light detector 66.
The NIRS processing circuitry 46 is further adapted to process the signals of the light detectors to filter the contribution of the surface by comparing the signals coming from the light detectors 66 and applying a diffusion model.
As a specific example, the diffusion model could be derived from Beer-Lambert law or by using a spatially resolved spectroscopy technique, often named SRS technique.
SRS technique is notably used in NIRS to obtain tissue oxygenation index (TOI). The minimal contamination from superficial layers is obtained by measuring the gradient of light-intensity attenuation at multiple wavelengths. For this, a set of closely placed detectors is used at nearly the same source-detector distance, large enough to probe the cerebral tissue
The filtering part corresponds to exploiting the property according to which it is generally considered that the tissue depth imaged is equal to half the distance between the emitter and the detector. This means that for short distances between the emitter and the detector (short channel) only the surface contribution is obtained and for long distances between an emitter and the corresponding detector (long channel), surface and cerebral tissue are imaged. By smartly filtering the long channel images by one or several short channel images, the systemic contribution is eliminated.
So as to increase such filtering approach of the systemic contribution, according to one embodiment, the four locations are aligned.
The same effect is obtained for three aligned locations.
In variant, the locations are arranged along other forms, such as circle or a square
It is also preferred that the distance between one location and the nearest location be comprised between 2 mm and 15 mm.
Description of an example of mechanical support 32
An example of mechanical support 32 is illustrated by figures 5 to 9.
The mechanical support 32 comprises two parts: a holding element 74 and a protecting element 76.
The holding element 74 can be viewed in more details on figures 6 and 7.
The holding element 74 is adapted both to hold the housing 30 and ensure that the intrapartum measurement probe 29 be held in place by pressure, wedged between the head of the fetus and the uterine wall.
As a specific example, the holding element 74 is made in a gecko adhesive material.
The holding element 74 comprises a central portion 78 and a peripheral portion 80 surrounding the central portion.
Seen from above, the holding element 74 has a general form of a rectangle while seen from a side, the transversal section (along the axis VI-VI on figure 6) has a form of a cup 82 with a bottom 84 and two sides 86 extending from the bottom towards the exterior.
The bottom 84 of the cup 82 corresponds to the central portion 78 while the sides 86 of the cup 82 correspond to the peripheral portion 80.
The bottom 84 and each side 86 form an angle comprised between 35° and 45°.
In the present case, the angles formed by the bottom 84 and each side 86 have the same values to simplify the manufacturing (by molding notably) of the holding element 74.
The central portion 78 is provided with fixing elements 88. The fixing elements 88 protrude from the central portion 78 and are intended to collaborate with complementary elements present on a face 90 of the housing 30.
The other face 92 of the housing 30 can be seen on figures 8 and 9.
The other face 92 has a rectangular shape with a length comprised between 20 mm and 40 mm and a width comprised between 4 mm and 10 mm.
The other face 92 comprises seven openings : two for the electrodes (electrode opening 94 hereinafter), one for the insertion of the fiber of the light source (light source opening 96 hereinafter) and four for the insertion of the fours fibers of the light detectors (light detector opening 98 hereinafter).
The distance between the two electrode openings 94 is comprised between 15 mm and 30 mm.
In addition, the distance between the light source opening 96 and the nearest light detector opening 98 is comprised between 2 mm and 20 mm.
One electrode opening 94 is located in front of the light source opening 96 while the other electrode opening 94 is located between two light detector openings 98, more precisely between the central light detector openings 98.
Such arrangement enables to avoid crosstalk between both modalities (EEG and NIRS).
The fibers 72 are fixed by one lateral side 100 of the housing 30, which enables to obtain a quite low voluminous housing 30. For this, the lateral side is provided with holding openings 102 through with the fibers 72 are inserted.
The protecting element 76 is adapted to protect the openings 94, 96 and 98, and more precisely the sensors 34 and 36.
Description of another example of mechanical support 32
Another example of mechanical support 32 is illustrated on figures 10 and 11 .
The housing 30 comprises here two parts 110 and 112.
The different elements of the intrapartum measurement probe are shared between the two parts 1 10 and 112.
Each part 1 10 and 112 has the general form of a cup.
In addition, each part 110 and 112 holds on the head of the fetus by suction, so that the parts 110 and 1 12 correspond a suction cup.
The mechanical support 32 comprises a connecting structure 114 linking the two parts 1 10 and 1 12 and, for each part 110 and 112, respectively a control rod 116 and a cable 1 18.
The connecting structure 114 is soft enough to follow the head curvature of the fetus. As apparent from figure 11 , each control rod 1 16 is linked to its respective part 110 or 112 by a receptacle 120, the receptacle being fixed to the bottom of the part 110 or 112.
The control rods 1 16 enable to control the angle between the two parts 110 and 1 12 by pushing one and/or pulling the other one.
Each cable 118 embeds one beam of optical fibers.
Description of an example of processing circuitry
The EEG processing circuit 40 and the NIRS processing circuit 46 have different sampling rates so that they work in an asynchronous manner.
This implies that the probe processing circuit 56 is provided with a synchronization unit adapted to synchronize the data coming from the EEG processing circuit and the NIRS processing circuit by using their local timestamp.
In other words, each of the EEG processing circuit 40 and the NIRS processing circuit 46 are able to timestamp an element with a timestamp derived from their own sampling rates. The synchronization unit will thus calculate the real time and synchronize the data with the same “absolute” timestamp.
Interests of the intrapartum measurement device 22
The intrapartum measurement device 22 enables to address the challenge of designing and developing a device and probe that provide reliable access for the monitoring of fetal cerebral oxygenation simultaneously to neuronal activity and heart rate while the cervix must be sufficiently dilated and the membranes ruptured.
Notably, the scalp is covered by hair, and mucous, blood etc., all of which can interfere with light transmission and photodetection. In addition, a good contact between the probe and the skin should also be obtained while pressure sores from the probes should be minimized.
For this, the present intrapartum measurement device 22 fulfills many technical constraints, among which medical constraints of maneuverability, accessibility, compatibility, technical constraints related to electrodes and EEG signal analysis, technical constraints related NIRS carrying out and NIRS signal analysis and modality mergers constraints.
Such intrapartum measurement device 22 is provided with synchronization and the real-time functionalities, which renders such device adapted to be used as an autonomous monitoring device.
Combining an EEG sensor 34 and a NIRS sensor 16 in the same intrapartum measurement device 22 provides with a simultaneous measurement bimodality ability. Such property enables to address the function/dysfunction of both hemodynamic and neuronal activities independently but also conjointly so as to minimize misleading interpretation arising from one or the other modalities.
The intrapartum measurement device 22 also provides with a better understanding of the mechanisms involved in this situation of normal or pathological delivery.
In addition, such intrapartum measurement device 22 enables to address specifically neurovascular origin and consequences of an acute cerebral distress during delivery. Such knowledge enables to prevent neurological sequels of postpartum, which appear later in development and can be declined in the form of various brain diseases ranging from death, cerebral palsy and cognitive disorders.
The intrapartum measurement device 22 also provides with information on cerebral function / dysfunction in all situations where one or the other of the modalities would be inoperative, thus making it possible to go beyond the limits of each of the techniques that have hitherto been proposed.
The intrapartum measurement device 22 enables to accurately and rapidly recognize oxygen delivery and tissue hypoxia in the critical labor situation.
The intrapartum measurement device 22 also strengthens the bundle of arguments considering the opportunity of a C-section.
Other embodiments of the intrapartum measurement device 22
Other embodiments of the intrapartum measurement device 22 may be considered. Some examples are given hereinafter.
As a first example, the intrapartum measurement device 22 further comprises a set of biosensors.
For instance, the intrapartum measurement device 22 also comprise a pressure sensor.
As a second example, since the EEG signals of human fetus are generally very weak, the intrapartum measurement device 22 is provided with a specific detecting module.
For instance, the detecting module comprises a filtering unit.
The filtering unit is adapted reduce the EEG signal contamination induced by movement artifacts, notably labor.
As a specific embodiment, the movement artifacts may be detected by using the pressure sensor mentioned in the first example of this paragraph.
Alternatively or in complement, the detecting module may also comprises a preamplifier with high common-mode rejection ratio and high signal-to-noise ratio.

Claims

1.- An intrapartum near-infrared spectroscopy device (44) adapted to carry out a near-infrared spectroscopy on the fetus’s brain, the intrapartum near-infrared spectroscopy device (44) comprising:
- a near-infrared spectroscopy sensor (36) being a fibered component comprising a light source (64) and at least two light detectors (66), the light detectors (66) being arranged to collect the light emitted by the fetus’s brain at two distinct locations, the light emitted by the fetus’s brain comprising a contribution from the surface of the skin of the fetus and a contribution from the brain, and
- a processing circuitry (46) adapted to receive the signals coming from the light detectors (66) and to process the signals of the light detectors (66) to filter the contribution of the surface by comparing the signals coming from the light detectors (66) and applying a diffusion model.
2.- The intrapartum near-infrared spectroscopy device according to claim 1 , wherein the light source (64) comprises several excitation sources (68) combined by couplers (70).
3.- The intrapartum near-infrared spectroscopy device according to claim 1 or 2, wherein for each light detector (66), a central wavelength is defined, each central wavelength being comprised between 600 nanometers and 1 100 nanometers.
4.- The intrapartum near-infrared spectroscopy device according to any one of claims 1 to 3, wherein for each excitation source (68), a central wavelength is defined, each central wavelength being comprised between 620 nanometers and 970 nanometers.
5.- The intrapartum near-infrared spectroscopy device according to any one of claims 2 to 4, wherein the number of excitation sources (68) is superior to 3.
6.- The intrapartum near-infrared spectroscopy device according to any one of claims 1 to 5, wherein each light detector (66) is provided with a fiber (72).
7.- The intrapartum near-infrared spectroscopy device according to claim 6, wherein at least one fiber (72) is a PMMA multimode fiber.
8.- The intrapartum near-infrared spectroscopy device according to claim 6 or 7, wherein at least one fiber (72) is a series of a PMMA multimode fiber and a SiC>2 multimode fiber.
9.- The intrapartum near-infrared spectroscopy device according to any one of claims 1 to 8, wherein at least one fiber (72) is provided with a prism.
10.- The intrapartum near-infrared spectroscopy device according to any one of claims 1 to 9, wherein the near-infrared spectroscopy sensor (36) comprises more than three light detectors (66), notably four light detectors (66).
11.- The intrapartum near-infrared spectroscopy device according to claim 10, wherein the locations are aligned.
12.- The intrapartum near-infrared spectroscopy device according to any one of claims 1 to 11 , wherein the distance between one location and the nearest location is comprised between 2 millimeters and 15 millimeters.
13.- An intrapartum measurement device (22) comprising an intrapartum nearinfrared spectroscopy device (36) according to any one of the claims 1 to 12.
14.- The intrapartum measurement device (22) according to claim 13, wherein the intrapartum measurement device (22) further comprises a electroencephalography device (38).
15.- A delivery monitoring system (10) comprising an intrapartum measurement device (22) according to claim 13 or 14.
PCT/EP2023/070327 2022-07-22 2023-07-21 Intrapartum measurement near-infrared spectroscopy device WO2024018071A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP22306101 2022-07-22
EP22306101.1 2022-07-22

Publications (1)

Publication Number Publication Date
WO2024018071A1 true WO2024018071A1 (en) 2024-01-25

Family

ID=83271168

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2023/070327 WO2024018071A1 (en) 2022-07-22 2023-07-21 Intrapartum measurement near-infrared spectroscopy device

Country Status (1)

Country Link
WO (1) WO2024018071A1 (en)

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5109849A (en) 1983-08-30 1992-05-05 Nellcor, Inc. Perinatal pulse oximetry sensor
US5435309A (en) * 1993-08-10 1995-07-25 Thomas; Edward V. Systematic wavelength selection for improved multivariate spectral analysis
US6175751B1 (en) * 1999-03-16 2001-01-16 Allen Maizes Apparatus and method for sensing oxygen levels in a fetus
US6175753B1 (en) 1999-07-02 2001-01-16 Baltimore Biomedical, Inc. Methods and mechanisms for quick-placement electroencephalogram (EEG) electrodes
US20040116789A1 (en) 2000-01-28 2004-06-17 Boas David Alan Fetal pulse oximetry
US20060161054A1 (en) * 1999-04-14 2006-07-20 Reuss James L Limited use medical probe
US20160089067A1 (en) 2013-05-24 2016-03-31 National University Corporation Hamamatsu University School Of Medicine Near infrared oxygen concentration sensor for palpation
WO2021195299A1 (en) 2020-03-24 2021-09-30 Raydiant Oximetry, Inc. Systems, devices, and methods for performing fetal oximetry and/or fetal pulse oximetry using a transvaginal fetal oximetry probe, transcervical fetal oximetry probe, and/or transurethral fetal oximetry probe

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5109849A (en) 1983-08-30 1992-05-05 Nellcor, Inc. Perinatal pulse oximetry sensor
US5435309A (en) * 1993-08-10 1995-07-25 Thomas; Edward V. Systematic wavelength selection for improved multivariate spectral analysis
US6175751B1 (en) * 1999-03-16 2001-01-16 Allen Maizes Apparatus and method for sensing oxygen levels in a fetus
US20060161054A1 (en) * 1999-04-14 2006-07-20 Reuss James L Limited use medical probe
US6175753B1 (en) 1999-07-02 2001-01-16 Baltimore Biomedical, Inc. Methods and mechanisms for quick-placement electroencephalogram (EEG) electrodes
US20040116789A1 (en) 2000-01-28 2004-06-17 Boas David Alan Fetal pulse oximetry
US20160089067A1 (en) 2013-05-24 2016-03-31 National University Corporation Hamamatsu University School Of Medicine Near infrared oxygen concentration sensor for palpation
WO2021195299A1 (en) 2020-03-24 2021-09-30 Raydiant Oximetry, Inc. Systems, devices, and methods for performing fetal oximetry and/or fetal pulse oximetry using a transvaginal fetal oximetry probe, transcervical fetal oximetry probe, and/or transurethral fetal oximetry probe

Similar Documents

Publication Publication Date Title
US11717210B2 (en) Depth of consciousness monitor including oximeter
US8428674B2 (en) Apparatus for spectrometric based oximetry
US6934570B2 (en) Physiological sensor combination
US9498158B2 (en) Optical sensor path selection
EP2672893B1 (en) Nirs sensor assembly including electrically conductive and optically transparent emi shielding
JP3725156B2 (en) Optical coupler for in vivo examination of biological tissue
US6285896B1 (en) Fetal pulse oximetry sensor
US4784150A (en) Surgical retractor and blood flow monitor
EP0686372A1 (en) Device for monitoring body functions
EP1219241A1 (en) Stethoscope
WO2010082748A2 (en) Form of a sensor module for measuring a photoplethysmogram for removing a motion artifact and method
JP5435134B2 (en) Holder and optical measuring device using the same
US8805465B2 (en) Multiple sensor assemblies and cables in a single sensor body
CN103619239A (en) Diagnostic measuring apapratus with integrated spectrometer
US20230337957A1 (en) Multi-sensor patch
WO2024018071A1 (en) Intrapartum measurement near-infrared spectroscopy device
WO2024018066A1 (en) Intrapartum measurement probe and device and delivery monitoring system
WO2011114479A1 (en) Holder and light measuring device using same
JP2005013464A (en) Biological light measuring instrument
CN220124689U (en) Probe device with brain blood oxygen and brain electrical signal synchronous acquisition function
Harper et al. Infrared transfer of electrophysiologic signals during magnetic resonance imaging

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 23742113

Country of ref document: EP

Kind code of ref document: A1